Skip to main content
Premium Trial:

Request an Annual Quote

Bioscientia Joins Siemens/Sequenom Partnership to Evaluate MassArray for Clinical Dx

NEW YORK, June 9 (GenomeWeb News) - Bioscientia, a reference laboratory based in Germany, will join Siemens Medical Solutions and Sequenom to evaluate Sequenom's MassArray platform for molecular diagnostic applications, Sequenom said today.

 

Under the agreement, Sequenom will provide its MassArray Compact platform, consumables, technical support, and assays for specific conditions, including deep vein thrombosis and HIV. With funding and engineering expertise from Siemens, Bioscientia will test the platform in a benchmarking study.

 

Bioscientia, based in Ingelheim, is the second reference lab after Specialty Laboratories in April to join Siemens' and Sequenom's "working group," which the companies founded in late 2004. The first phase of the progam, which will eventually include four laboratories, will be a benchmarking study, to be completed this year, to evaluate the analytical data quality and workflow of the MassArray system.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.